Generics 1



Medical devices



Reteplase manufacturers

1 products found



Filters , active

Country of origin : China

Clear all

1 products found


Solution for injection 5MIU

Dossier type
Dossier status
Ready to file
Country of origin
GMP approvals
Manufacturer #16892

Manufacturer usually replies in 6 days

Reteplase Manufacturers

Reteplase is sold under the trade names “Retevase”, “Retefuse”, “Rapilysin”, and “Mirel” among others. It is classified under the drug class Thrombolytic drugs. It is indicated for the treatment of Acute pulmonary emboli, intracoronary emboli, acute myocardial infarction, cardiovascular mortality, and congestive heart failure. It is mostly administered through an intravenous route through an IV line. Anticoagulant/antiplatelet herbs and supplements should be avoided when taking this medication. Garlic, ginger, bilberry, danshen, piracetam, and ginkgo Biloba are some of the examples. Reteplase and heparin are incompatible drugs. It should not be administered through a heparin-containing intravenous line. This drug should be stored between 2°C and 25°C (36°F and 77°F). To protect the lyophilisate from exposure to light, the box should be sealed until it is time to use it. Adverse effects of this pharmaceutical medicine include fever, bleeding of the injection site, bloody stool, blood in urine, stomach pain, and/or vomiting blood. This pharmaceutical medicine is mostly contraindicated in conditions, such as if patients have gone through spine operation, brain tumor, retinal disease hemorrhage in diabetic patients, increased risk of bleeding due to clotting disorder, and bleeding from the retina. It is not usually prescribed for pregnant women as it may cause harm to the fetus. In lactating women, there is no data found of its secretion into milk but precautions are necessary to be taken. It should be only prescribed if benefits are more than risks. It was approved by FDA on October 30, 1996, under the brand name Retevase.

How does Retaplase work?

It works by eliminating blood clots by breaking Arg/Val bond in plasminogen and form plasmin which in turn breaks the fibrin matrix, resulting in thrombolytic action.

The cost of Reteplase

For supply of 1 kit of Reteplase intravenous containing 10 units, it costs approximately $3,383.

Sourcing the Reteplase Manufacturer and Suppliers

Navigating our pharmaceutical marketplace

Pipelinepharma being a global B2B online marketplace is formulated to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to interact with. The list of Reteplase offerings can be narrowed down with the use of filters and easily weighed compared against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries that manufacture this pharmaceutical medicine. These also enable you to check the dossier status of this medicine, and the GMP approvals of the different variants of Reteplase. Each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where Reteplase is already registered in. Manufacturers and suppliers may also have specific delivery terms.

Establishing commercial ties

Finding a trustworthy business partner is one of the most difficult challenges, and to overcome that challenge and make it easier to find the trusted manufacturer and supplier, one can visit the Pipelinepharma website, which assists you in finding the trusted manufacturers and suppliers. Pipelinepharma is a business-to-business (B2B) licensing marketplace for pharmaceutical medicines that links the seller with customers quickly for business development.

Quality assurance

Pipelinepharma validates the quality of drugs and their expiration date. The site conducts proper quality-control operations and investigates every drug thoroughly, so if any flaws are detected they can be addressed before marketing it.